A PHASE 3, OPEN-LABEL, MULTICENTER STUDY OF ALXN1210 IN CHILDREN AND ADOLESCENTS WITH ATYPICAL HEMOLYTIC-UREMIC SYNDROME (aHUS)
Clinical Trial Grant
Administered By
Pediatrics, Nephrology
Awarded By
Alexion Pharmaceuticals, Inc.
Start Date
August 10, 2017
End Date
January 31, 2020
Administered By
Pediatrics, Nephrology
Awarded By
Alexion Pharmaceuticals, Inc.
Start Date
August 10, 2017
End Date
January 31, 2020